Cognitive ^ behavioural therapy andmotivational intervention for schizophrenia andsubstancemisuse 18-month outcomes of a randomised controlled trial

Declaration of interest None. Fundingdetailed in Acknowledgements. Studies have indicated that cognitive– behavioural therapy (CBT) plus treatment as usual for patients with schizophrenia have significant benefits on relapse and patient functioning (Pilling et al, 2002; Cormac et al, 2003). However, the application of CBT to psychotic disorders involving substance use has been evaluated very little, or where evaluations have been reported the findings have been limited by poor methodology (Ley et al, 2001). The current study evaluated the effectiveness of an individual and family-oriented CBT programme for chronic treatment-resistant psychosis combined with motivational intervention for substance use problems over an 18-month follow-up period. Preliminary findings on patient outcome from the treatment phase of the study have been reported already (Barrowclough et al, 2001). The aim of the current study was to investigate whether the integrated programme of interventions had a beneficial effect on illness, substance use, carer and health economy outcomes over 18 months.

[1]  I. Cormac,et al.  Cognitive behaviour therapy for schizophrenia , 2002 .

[2]  S. Hirsch,et al.  The Social Behaviour Assessment Schedule (SBAS): Rationale, contents, scoring and reliability of a new interview schedule , 1980, Social psychiatry.

[3]  P Bebbington,et al.  Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy , 2002, Psychological Medicine.

[4]  N. Tarrier,et al.  Cognitive behaviour therapy for patients with co-existing psychosis and substance use problems. , 2002 .

[5]  C. Barrowclough,et al.  Schizophrenia and substance misuse problems: a comparison between patients with and without significant carer contact , 2001, Social Psychiatry and Psychiatric Epidemiology.

[6]  N. Tarrier,et al.  AN INVESTIGATION INTO THE PSYCHOMETRIC PROPERTIES OF THE COGNITIVE THERAPY SCALE FOR PSYCHOSIS (CTS-Psy) , 2001, Behavioural and Cognitive Psychotherapy.

[7]  B. Delaney,et al.  Cost effectiveness of initial endoscopy for dyspepsia in patients over age 50 years: a randomised controlled trial in primary care , 2000, The Lancet.

[8]  A. Ley,et al.  Treatment programmes for people with both severe mental illness and substance misuse. , 2000, The Cochrane database of systematic reviews.

[9]  K Claxton,et al.  The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies. , 1999, Journal of health economics.

[10]  Philip D. Harvey,et al.  Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40 , 1998, BMJ.

[11]  W. Sellwood,et al.  Assessing relatives' needs for psychosocial interventions in schizophrenia: a relatives' version of the Cardinal Needs Schedule (RCNS) , 1998, Psychological Medicine.

[12]  Linda C. Sobell,et al.  Timeline Follow-Back A Technique for Assessing Self-Reported Alcohol Consumption , 1992 .

[13]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.

[14]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[15]  William Spinks The University of Manchester , 1926, Nature.